added 563,562 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,460,355 LOOMIS SAYLES & CO L P added 419,077 shares (+38.4%) to their portfolio in Q3 2025, for an estimated $9,265,792 VANGUARD GROUP INC added 417,790 shares (+642.8%) to their portfolio in Q3 2025, for an estimated $9,237,336 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
Initial concerns regarding the possible link between the use of GLP-1 RAs and the development of pancreatitis or pancreatic cancer have not been supported by the results of RCTs [53,54], or real-world data [29,55,56]
Starting a new medication can sometimes lead to unexpected side effects
Pediatrics 2004
I had Covid-19 recently and this has knocked me about